Dietary Protein and Resistance Exercise in Elderly (NUTRIAGINGPROT)

July 17, 2019 updated by: Karl-Heinz Wagner, University of Vienna

Effects of Low or High Amounts of Dietary Protein and Resistance Training on Community-dwelling Older Adults: a Randomized Controlled Trial

The aim of this randomized, observer-blind, controlled intervention study with parallel groups is to study the effect of resistance training (2x/week for 8 weeks) with and without different goals of protein intake on muscle strength, function and mass, oxidative stress parameters and the immune system in community dwelling persons.

Participants (n = 137) will be community-dwelling older adults. After a pre-participation screening participants will be distributed randomly but stratified by sex and age to one of the 3 groups (low protein + strength training, high protein + strength training, low protein and no strength training(=control)). Study participants are eligible if they are male or female with an age between 65 and 85 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the training sessions, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, a frailty index at or above 3, medication with anticoagulants or cortisone drugs and also regular strength training during the last six months.

Primary outcome measure is the change in the Chair Stand Test. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters, microbiota, metabolomics, proteomics and the nutritional status.

Study Overview

Study Type

Interventional

Enrollment (Actual)

137

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1090
        • University of Vienna, Department of Nutritional Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Males and females between the age of 65 and 85 years of age
  • Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23)
  • Independently mobile

Exclusion Criteria:

  • Chronic diseases, which contraindicate a training participation
  • Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)
  • Diabetic retinopathy
  • Manifest osteoporosis
  • Regular use of cortisone-containing drugs
  • Regular strength training (> 1x / week) in the last 6 months before inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Strength Training and Protein high
6 weeks of high protein intake (additional 1g/kg bw/d) followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains.
6 weeks of high protein intake mainly via food (additional 1g/kg bw/d) followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains.
6 weeks of different protein intake followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains
EXPERIMENTAL: Strength Training and Protein low
6 weeks of low protein intake (1g/kg bw/d) followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains.
6 weeks of different protein intake followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains
6 weeks of low protein intake (1g/kg bw/d) followed by a 8 weeks resistance training (Progressive strength training in a fitness center is applied; the intensity is adjusted continuously in order to obtain a sufficient training stimulus). During the training period the protein intake remains
OTHER: Control
No Intervention.
No Intervention, control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in chair stand test (repetitions)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The maximum number of completed cycles of unsupported chair rises (from a seated to a fully erected position (hip and knees straightened)) completed within 30 s is counted.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in isometric quadriceps peak torque (Nm/kg)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Isokinetic peak torque measurements of knee extensors and flexors will be performed using a LIDO Multijoint II isokinetic loading dynamometer. Participants will be tested in a sitting posion with their hip flexed at approximately 90° and subjects securely strapped to the seat of the chair using adjustable trunk and waist stabilisation belts. The anatomic axis of the knee rotation at the knee joint will aligned with the machine axis of rotation to insure similar movements for all participants. Two continuous maximal repetitions of knee extensors and knee flexors will be performed concentrically at each angular velocity (60°/s and 120°/s) for peak torque recording.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in handgrip strength (kg)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Handgrip strength of the right hand will be measured to the nearest kilogram (kg) using a hand Dynamometer. Participants will be encouraged to perform a maximal contraction within approximately 4 to 5 s. After a rest of 60 s, participants will be asked to perform a second trial. The highest score of maximum voluntary contraction will be used for data analyses.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in muscle mass with BIA (kg)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in 6min walking test (distance in meter)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in the composition of gut-microbiota
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Gene sequencing of the 16S rRNA on the stool samples are performed to identify the microbes down to genus level, as well as the microbrobiota diversity and relative abundance.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in stool short-chain fatty acids (SCFAs)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The stool short-chain fatty acids (SCFAs) will be extracted and quantitatively analysed by gas chromatography.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in oxidative stress marker such as malondialdehyd
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The investigators will consider changes in plasma concentrations of oxidative stress marker such as malondialdehyde from baseline to the end of the intervention.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in inflammatory marker (i.g. IL-6, TNF-alpha)
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The investigators will consider changes in plasma concentrations of Interleukin 1 (IL-1), IL-6, IL-8, IL-10, TNF-alpha
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in the metabolomics response
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The metabolomic response (ie all metabolites) to the interventions will be analyzed using both nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques. Patterns of metabolites will be evaluated with statistical techniques, ie discriminant analysis and principal component analysis.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
Change from baseline in the amino acid pattern
Time Frame: baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)
The plasma amino acid pattern will be assessed with HPLC-MS.
baseline, after dietary intervention (6 weeks) and after dietary and strength training (14 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2018

Primary Completion (ACTUAL)

February 28, 2019

Study Completion (ANTICIPATED)

January 1, 2021

Study Registration Dates

First Submitted

June 15, 2019

First Submitted That Met QC Criteria

July 16, 2019

First Posted (ACTUAL)

July 17, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 22, 2019

Last Update Submitted That Met QC Criteria

July 17, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • FA219002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on High protein intake

3
Subscribe